2019-08312. National Heart, Lung, and Blood Institute; Notice of Meeting  

  • Start Preamble

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Sickle Cell Disease Advisory Committee.

    The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

    Name of Committee: Sickle Cell Disease Advisory Committee.

    Date: May 31, 2019.

    Time: 8:30 a.m. to 2:30 p.m.

    Agenda: Discussion of Programs.

    Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892.

    Contact Person: W. Keith Hoots, MD, Director, Division of Blood Diseases and Resources, National Heart, Lung, and Blood Institute, National Institutes of Health, 6701 Rockledge Drive, Suite 9030, Bethesda, MD 20892, 301-435-0080, hootswk@nhlbi.nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.233, National Center for Sleep Disorders Research; 93.837, Heart and Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, Blood Diseases and Resources Research, National Institutes of Health, HHS)

    Start Signature

    Dated: April 19, 2019.

    Ronald J. Livingston, Jr.,

    Program Analyst, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 2019-08312 Filed 4-24-19; 8:45 am]

    BILLING CODE 4140-01-P

Document Information

Published:
04/25/2019
Department:
Health and Human Services Department
Agency:
National Institutes of Health
EntryType:
Notice
Document Number:
2019-08312
Dates:
May 31, 2019.
Pages:
17416-17416 (1 pages)
SectionNoes:
PDF File:
2019-08312.pdf